Navigating Clinical Trials: The Challenges Patients Face

For many individuals with chronic conditions, the prospect of participating in clinical trials can be a beacon of hope. Yet, the journey from interest to enrollment is fraught with obstacles. A recent survey highlighted that while 71% of patients expressed a willingness to join a clinical trial, a staggering two-thirds of respondents reported that their healthcare providers had never broached the subject.

The recruitment process for clinical trials is notoriously challenging, with studies indicating that up to 86% fail to meet their enrollment goals. Alan Balch, the executive board chair at the Patient Advocate Foundation, emphasizes that securing participants is only part of the equation; retaining them throughout the trial is equally critical. "Every touchpoint is an opportunity for access and affordability to be a problem," he noted.

Amid ongoing efforts to enhance patient participation, the Department of Health and Human Services recently announced a drive to streamline clinical research. This initiative includes a call for feedback on potential changes to regulations that currently inhibit sponsors from reimbursing trial participants for travel and other expenses. Additionally, advocacy groups have rallied behind the Clinical Trial Modernization Act, which, if passed, would allow sponsors to cover medical costs and exempt financial support from federal taxes.

Clinical trials are vital for testing new treatments, ranging from drugs and medical devices to lifestyle interventions. For patients battling severe illnesses, these trials can sometimes offer the best chance to extend life or improve its quality. As Mark Fleury from the American Cancer Society pointed out, clinical trials can provide options when standard care falls short.

Despite their potential benefits, many patients struggle to identify suitable clinical trials. A survey indicated that even though 86% of primary care physicians were open to referring patients, only 37% had actually done so. The difficulty lies in the time-consuming nature of searching for trials that match patient profiles. Community oncologists, for instance, often have to navigate complex databases and may lose their patients to trial sites if they are successful in finding a match.

For those determined to participate, several patient advocacy organizations provide resources to help locate trials. The American Cancer Society, for instance, offers a clinical trial matching service, alongside others like the Arthritis Foundation and the National Multiple Sclerosis Society, which maintain databases of disease-specific trials.

However, even when a relevant trial is found, geographic limitations can pose significant barriers. A recent study revealed that 55.6% of cancer patients did not have access to any available trial for their specific type and stage of cancer at their treatment facility. Furthermore, 21.5% of patients did not qualify for the trials that were available.

In order to pursue a clinical trial, patients should reach out directly to trial recruiters to inquire about eligibility and logistics. As Balch advises, this is merely the starting point; understanding the full scope of participation requirements is crucial.

Source: kffhealthnews.org